Aberrant opioid use behaviour in advanced cancer.

Sebastiano MercadanteClaudio AdileWalter TirelliPatrizia FerreraItalo PencoAlessandra Casuccio

Published in: BMJ supportive & palliative care (2020)

Despite a high percentage of patients showed a high risk of aberrant behaviours, no patient displayed clinical aberrant behaviours after 1 month-follow-up. This does not exempt from continuous monitoring for patients who are at risk.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
advanced cancer
prognostic factors
peritoneal dialysis